Concepedia

Charles J. Andres

CJ

Statistics

Publications

5

Citations

383

H-Index

5

Active since

1993

Affiliations

Bristol-Myers Squibb (United States)(Current)

Charles J. Andres is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1993–2006

5

Publications

5

4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB

Charles J. Andres, Joanne J. Bronson, Stanley V. D’Andrea et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 220 citations

, , +9

Asymmetric routes to azasugars from chiral bicyclic lactams. Synthesis of 1,4-dideoxy-1,4-imino-D-lyxitol; L-deoxymannojirimycin; rhammo-1-deoxynojirimycin and 1-deoxy-6-epicastanospermine

A. I. MEYERS, Charles J. Andres, James E. Resek et al. · Tetrahedron · 1999 · 67 citations

, , +9

Conformationally defined analogs of prolylamides. trans-Prolyl peptidomimetics

Charles J. Andres, Timothy L. Macdonald, Timothy D. Ocain et al. · The Journal of Organic Chemistry · 1993 · 39 citations

, , +6

Application of Lean Manufacturing Concepts to Drug Discovery:  Rapid Analogue Library Synthesis

Harold N. Weller, David S. Nirschl, Edward W. Petrillo et al. · Journal of Combinatorial Chemistry · 2006 · 36 citations

, , +15

Differentially functionalized diamines as novel ligands for the NPY2 receptor

Charles J. Andres, I Zimányi, Milind Deshpande et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 21 citations · Full text

, , +14

1–5 of 5